Company Catabasis Pharmaceuticals Inc Nasdaq
Equities
US14875P1075
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 26/08/26 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 01/11/01 |
Chief Tech/Sci/R&D Officer | - | 15/22/15 | |
John Ruesch
PRN | Corporate Officer/Principal | - | 17/23/17 |
Keri McGrail
HRO | Human Resources Officer | - | 01/21/01 |
Andrew Komjathy
PRN | Corporate Officer/Principal | 61 | 25/19/25 |
Ben Harshbarger
LAW | General Counsel | 55 | 12/20/12 |
Andrea Matthews
PRN | Corporate Officer/Principal | - | 01/14/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 01/14/01 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 04/19/04 |
Director/Board Member | 75 | 05/16/05 | |
Jonathan Violin
BRD | Director/Board Member | 49 | 28/21/28 |
Jill Milne
FOU | Founder | 56 | 26/08/26 |
Hugh Cole
BRD | Director/Board Member | 59 | 26/19/26 |
Joanne Beck
BRD | Director/Board Member | 63 | 14/19/14 |
Director/Board Member | 56 | 28/21/28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,913,061 | 48,159,943 ( 87.70 %) | 0 | 87.70 % |
Stock B | 0 | 31,107 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.58% | 115B | |
+12.41% | 107B | |
-12.38% | 22.31B | |
-3.46% | 21.6B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B | |
-24.50% | 8.28B |